Richman Michael 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jan 28, 2020
Insider Transaction Report
Form 4
Richman Michael
Director
Transactions
- Award
Stock Option (right to buy)
2020-01-25+20,000→ 20,000 totalExercise: $3.23Exp: 2030-01-25→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2020-01-25$2.11/sh+5,431$11,443→ 5,431 totalExercise: $3.23From: 2020-01-25Exp: 2030-01-25→ Common Stock (5,431 underlying)
Footnotes (2)
- [F1]The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $11,445.56 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears pursuant to the Issuer's non-employee director compensation policy.
- [F2]The stock option will vest as to 100% of the underlying shares on January 25, 2021, subject to the Reporting Person's continued service as a director through the vesting date.